Cargando…

Shingles and mRNA COVID‐19 vaccine

Detalles Bibliográficos
Autores principales:	Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Vaccine Society 2021
Materias:	COVID-19 Special
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511590/ https://www.ncbi.nlm.nih.gov/pubmed/34703814 http://dx.doi.org/10.7774/cevr.2021.10.3.292

Ejemplares similares

Myocarditis and COVID-19 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?
por: Aksu, Saliha Buşra, et al.
Publicado: (2021)

Vulvar Aphthous Ulcer and COVID-19 mRNA Vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

CMR Imaging After Myocarditis Associated with mRNA COVID-19 Vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

An autopsy case report of aortic dissection after mRNA COVID-19 vaccination: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination
por: Yagi, Yohsuke, et al.
Publicado: (2021)

Clinicopathological features of cutaneous reactions after mRNA‐based COVID‐19 vaccines
por: Tihy, M., et al.
Publicado: (2021)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)

Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

Atypical modes of COVID-19 transmission: how likely are they?
por: Wiwanitkit, Viroj
Publicado: (2020)

Heterologous prime-boost with the mRNA-1273 vaccine among CoronaVac-vaccinated healthcare workers in Indonesia
por: Santi, Theresia, et al.
Publicado: (2022)

A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
por: Miyamoto, Katsuichi, et al.
Publicado: (2022)

Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
por: Fotiadou, Aggeliki, et al.
Publicado: (2022)

Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers
por: Klingel, Hanna, et al.
Publicado: (2022)

Livedoid skin reaction and mRNA Covid-19 vaccine: correspondence
por: Mungunpuntipantip, Rujittika, et al.
Publicado: (2023)

Cardiac magnetic resonance characteristics of acute myocarditis occurring after mRNA-based COVID-19 vaccines immunization
por: Meyer-Szary, Jaroslaw, et al.
Publicado: (2022)

An Unusual Case Report of COVID-19 Presenting with Meningitis Symptoms and Shingles
por: Packwood, Rebecca, et al.
Publicado: (2020)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period
por: Joob, Beuy, et al.
Publicado: (2020)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
por: Tanzilli, Antonio, et al.
Publicado: (2022)

A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?
por: Barsha, Sabrina Yesmin, et al.
Publicado: (2021)

Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study
por: Kang, Yu Min, et al.
Publicado: (2021)

Thyrotoxicosis after COVID-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

COVID-19 Vaccination and Cancer: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Pituitary apoplexy and COVID-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Pituitary apoplexy and COVID-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Addressing COVID-19 vaccine hesitancy
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6t41bd8n470mqipcimgvac5aj